InnovaDerma PLC Notice of Results, Prospectus and General Meeting (0781T)
23 March 2021 - 1:25AM
UK Regulatory
TIDMIDP
RNS Number : 0781T
InnovaDerma PLC
22 March 2021
InnovaDerma PLC
("InnovaDerma" or the "Company")
Notice of Results, posting of Prospectus and General Meeting
InnovaDerma (LSE: IDP), a UK developer of beauty, personal care
and life sciences products, will announce its half year results for
the six months ending 31 December 2020 on Wednesday 31 March
2021.
The Company expects to post its Prospectus (which will also
comprise an open offer circular) shortly thereafter and hold a
General Meeting, with Second Admission (post shareholder approval)
occurring in mid April.
The Company will deliver an online presentation on the same day
as its results. It is open to all existing and potential investors
via the Investor Meet Company platform on Wednesday, 31 March at
9.30am UK time.
Investors can sign up for free via:
https://www.investormeetcompany.com/innovaderma-plc/register-investor
.
Investors who have already registered and added to meet the
Company will be automatically invited.
The presentation is in line with InnovaDerma's commitment to
ensuring appropriate communication structures are in place for all
sections of its shareholder base so that its strategy, business
model and performance are clearly understood.
Questions can be submitted pre-event through the platform or at
any time during the live presentation. Management may not be in a
position to answer every question it receives but will address
those it can while remaining within the confines of information
already disclosed to the market. Responses to the Q&A from the
live presentation will be published at the earliest opportunity on
the Investor Meet Company platform.
Investor feedback can also be submitted directly to management
post-event to ensure the Company can understand the views of all
elements of its shareholder base.
Unless otherwise defined herein, capitalised terms used in this
announcement shall have the same meanings as defined in the
announcement of the Fundraising made by the Company on 20 January
2021.
Further enquiries
InnovaDerma
Blake Hughes c/o TB Cardew
finnCap Group
Geoff Nash/Kate Bannatyne/Edward +44 (0)207 220 0500
Whiley www.finncap.com
Alice Lane - Corporate Broking
----------------------------
TB Cardew
Shan Shan Willenbrock/ + 44 (0)7775 848537
Olivia Rosser + 44 (0)20 7930 0777
innovaDerma@tbcardew.com
----------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCFLFFSVSIFFIL
(END) Dow Jones Newswires
March 22, 2021 10:25 ET (14:25 GMT)
Innovaderma (LSE:IDP)
Historical Stock Chart
From Apr 2024 to May 2024
Innovaderma (LSE:IDP)
Historical Stock Chart
From May 2023 to May 2024